Sarah Tomassetti

822 total citations
26 papers, 534 citations indexed

About

Sarah Tomassetti is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Sarah Tomassetti has authored 26 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 9 papers in Oncology and 7 papers in Genetics. Recurrent topics in Sarah Tomassetti's work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Sarah Tomassetti is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Sarah Tomassetti collaborates with scholars based in United States, Czechia and South Africa. Sarah Tomassetti's co-authors include Valerie Purdie‐Vaughns, Kevin R. Binning, Julio Garcia, David K. Sherman, Geoffrey L. Cohen, A. David Nussbaum, G. Canny, Charles N. Serhan, Eric L. Campbell and Makoto Arita and has published in prestigious journals such as Journal of Personality and Social Psychology, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sarah Tomassetti

24 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Tomassetti United States 5 123 118 99 72 61 26 534
Gang Cheng China 19 92 0.7× 37 0.3× 29 0.3× 105 1.5× 98 1.6× 46 1.1k
Jianqiang Hao United States 19 89 0.7× 43 0.4× 26 0.3× 188 2.6× 10 0.2× 39 998
Shan Zhao China 14 51 0.4× 41 0.3× 9 0.1× 30 0.4× 17 0.3× 42 744
Thomas Stewart Australia 16 53 0.4× 31 0.3× 15 0.2× 196 2.7× 87 1.4× 57 985
Sarah Fletcher United Kingdom 12 16 0.1× 118 1.0× 39 0.4× 34 0.5× 266 4.4× 22 564
Julie Brevard United States 11 42 0.3× 43 0.4× 5 0.1× 77 1.1× 9 0.1× 18 512
Minji Kim United States 15 95 0.8× 22 0.2× 27 0.3× 20 0.3× 8 0.1× 41 904
Linda Peterson United States 9 24 0.2× 49 0.4× 9 0.1× 94 1.3× 26 0.4× 20 463
Chiyoko Uchida Japan 15 54 0.4× 43 0.4× 9 0.1× 198 2.8× 25 0.4× 28 781

Countries citing papers authored by Sarah Tomassetti

Since Specialization
Citations

This map shows the geographic impact of Sarah Tomassetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Tomassetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Tomassetti more than expected).

Fields of papers citing papers by Sarah Tomassetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Tomassetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Tomassetti. The network helps show where Sarah Tomassetti may publish in the future.

Co-authorship network of co-authors of Sarah Tomassetti

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Tomassetti. A scholar is included among the top collaborators of Sarah Tomassetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Tomassetti. Sarah Tomassetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qing, Xin, et al.. (2025). CD19 Expression in B-Cell Lymphomas and Clinical Considerations in the Evolving Landscape of CD19-Targeted Therapy. World Journal of Oncology. 16(2). 235–238. 1 indexed citations
2.
Tomassetti, Sarah, et al.. (2024). Real-world treatment outcomes from a retrospective cohort of patients with acute myeloid leukemia from an urban safety net hospital. Journal of Oncology Pharmacy Practice. 31(2). 182–189. 1 indexed citations
3.
Tomassetti, Sarah, et al.. (2024). Treatment Outcomes for Patients with Hodgkin's Lymphoma at a Safety Net Hospital. Blood. 144(Supplement 1). 6357–6357.
4.
Narkhede, Mayur, Sarah Tomassetti, Madiha Iqbal, et al.. (2024). Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma. Frontiers in Oncology. 14. 1407003–1407003. 2 indexed citations
5.
Qing, Xin, et al.. (2024). Retrospective Study of CD20 Expression Loss in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. Journal of Hematology. 13(6). 268–277. 1 indexed citations
6.
Tomassetti, Sarah, et al.. (2023). Diffuse large B‐cell lymphoma presenting as postmenopausal bleeding. SHILAP Revista de lepidopterología. 11(11). e8173–e8173. 1 indexed citations
7.
Tomassetti, Sarah, et al.. (2023). Unexpected coccidioidomycosis presenting as lung nodules with presumptive diagnosis of malignancy. SHILAP Revista de lepidopterología. 11(12). e8316–e8316. 1 indexed citations
8.
9.
Tomassetti, Sarah, Jennifer M. Lee, & Xin Qing. (2022). A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib. SHILAP Revista de lepidopterología. 10(11). e6478–e6478. 3 indexed citations
10.
Tomassetti, Sarah, et al.. (2022). Case of concurrent factor VII and factor XI deficiencies manifesting as spontaneous lower extremity compartment syndrome. SHILAP Revista de lepidopterología. 10(4). e05710–e05710. 2 indexed citations
11.
Tomassetti, Sarah, et al.. (2022). CD20 and CD19 expression loss in relapsed or refractory b-cell non-Hodgkin lymphoma: A retrospective cohort.. Journal of Clinical Oncology. 40(16_suppl). e19537–e19537. 3 indexed citations
12.
Tomassetti, Sarah, et al.. (2022). Evaluating asparaginase toxicity in Hispanic patients with acute lymphoblastic leukemia in a large safety-net hospital.. Journal of Clinical Oncology. 40(16_suppl). e19012–e19012. 2 indexed citations
13.
Tomassetti, Sarah, et al.. (2021). Abnormal eosinophils with immature eosinophilic granules in chronic myeloid leukemia in accelerated phase. SHILAP Revista de lepidopterología. 9(9). e04783–e04783. 1 indexed citations
14.
Gianoukakis, Andrew G., et al.. (2021). Graves' disease patients with iron deficiency anemia: serologic evidence of co-existent autoimmune gastritis.. PubMed. 11(3). 238–247. 4 indexed citations
15.
Andorsky, David, Sarah Tomassetti, Yehuda E. Deutsch, et al.. (2021). Trial in Progress: Asciminib in Monotherapy 4 CML (AIM4CML), a Phase IIIb Study of Asciminib Monotherapy in Patients with Chronic Myeloid Leukemia in Chronic Phase without or with T315I Mutations. Blood. 138(Supplement 1). 3599–3599. 1 indexed citations
16.
Tomassetti, Sarah, Robert Chen, & Savita Dandapani. (2019). The role of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma. Therapeutic Advances in Hematology. 10. 24 indexed citations
17.
Chen, Robert W., Joycelynne Palmer, Sarah Tomassetti, et al.. (2018). Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation. Journal of Hematology & Oncology. 11(1). 87–87. 17 indexed citations
18.
Tomassetti, Sarah & Alex F. Herrera. (2018). Update on the role of brentuximab vedotin in classical Hodgkin lymphoma. Therapeutic Advances in Hematology. 9(9). 261–272. 4 indexed citations
19.
Pullarkat, Vinod, Zhuo‐Xian Meng, Vicky Yamamoto, et al.. (2014). Iron chelators induce autophagic cell death in multiple myeloma cells. Leukemia Research. 38(8). 988–996. 41 indexed citations
20.
Sherman, David K., Kevin R. Binning, Valerie Purdie‐Vaughns, et al.. (2013). Deflecting the trajectory and changing the narrative: How self-affirmation affects academic performance and motivation under identity threat.. Journal of Personality and Social Psychology. 104(4). 591–618. 248 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gang Cheng Breakdown of academic impact, for papers by Jianqiang Hao Breakdown of academic impact, for papers by Shan Zhao Breakdown of academic impact, for papers by Thomas Stewart Breakdown of academic impact, for papers by Sarah Fletcher Breakdown of academic impact, for papers by Julie Brevard Breakdown of academic impact, for papers by Minji Kim Breakdown of academic impact, for papers by Linda Peterson Breakdown of academic impact, for papers by Chiyoko Uchida
Rankless by CCL
2026